![Elmar Schärli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Elmar Schärli is currently the Director at Zilentin AG and the Chief Financial Officer at Xigen SA. Previously, he worked as the Chief Financial Officer at Altamira Therapeutics Ltd. from 2019 to 2021.
Aktive Positionen von Elmar Schärli
| Unternehmen | Position | Beginn |
|---|---|---|
Xigen SA
 Xigen SA Pharmaceuticals: MajorHealth Technology Develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer | Finanzdirektor/CFO | - |
Zilentin AG
 Zilentin AG BiotechnologyHealth Technology Develops and supplies peptide-based nanoparticles for efficient RNA delivery to extrahepatic tissues | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Elmar Schärli
| Unternehmen | Position | Ende |
|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Finanzdirektor/CFO | 01.11.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer | Health Technology |
Altamira Therapeutics Ltd.
 Altamira Therapeutics Ltd. BiotechnologyHealth Technology Develops RNA therapeutics for inner ear disorders | Health Technology |
Zilentin AG
Zilentin AG BiotechnologyHealth Technology Develops and supplies peptide-based nanoparticles for efficient RNA delivery to extrahepatic tissues | Health Technology |
